Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03774459
What this trial is testing

ANAVEX2-73 Study in Parkinson's Disease Dementia

Who this might be right for
Parkinsons Disease With Dementia
Anavex Life Sciences Corp. 132
Large-scale testing (Phase 3)Study completedNCT04889118
What this trial is testing

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study

Who this might be right for
Malignant Melanoma
Merck Sharp & Dohme LLC 131
Testing effectiveness (Phase 2)Ended earlyNCT05636852
What this trial is testing

Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

Who this might be right for
Parkinson DiseaseMovement Disorders
GE Healthcare 15
Testing effectiveness (Phase 2)Study completedNCT02939391
What this trial is testing

KW-6356 in Subjects With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 175
Not applicableEnrolling By InvitationNCT07808606
What this trial is testing

Parkinson's Improvement Activated by Hula Understanding (PAHU) - Part 2

Who this might be right for
Parkinson' Disease
University of Hawaii 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015841
What this trial is testing

Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinson Disease 6, Early-Onset
AC Immune SA 150
Testing effectiveness (Phase 2)Study completedNCT04995081
What this trial is testing

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 60
Testing effectiveness (Phase 2)Study completedNCT05424276
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Who this might be right for
Parkinson Disease
ABLi Therapeutics, Inc. 137
Not applicableStudy completedNCT02511015
What this trial is testing

Hereditary Parkinson s Disease Natural History Protocol

Who this might be right for
Parkinson Disease 6, Early-OnsetParkinson Disease (Autosomal Recessive, Early Onset) 7, HumanParkinson Disease Autosomal Recessive, Early Onset+1 more
National Heart, Lung, and Blood Institute (NHLBI) 31
Large-scale testing (Phase 3)Study completedNCT03783078
What this trial is testing

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

Who this might be right for
Merkel Cell Carcinoma
Merck Sharp & Dohme LLC 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04634877
What this trial is testing

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

Who this might be right for
Endometrial Neoplasms
Merck Sharp & Dohme LLC 990
Early research (Phase 1)Looking for participantsNCT06466525
What this trial is testing

A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.

Who this might be right for
Parkinson Disease
Longevity Biotech Australia Pty Ltd (subsidiary) 64
Testing effectiveness (Phase 2)Study completedNCT02933372
What this trial is testing

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3

Who this might be right for
Parkinson's Disease
University of Michigan 25
Testing effectiveness (Phase 2)Study completedNCT01336088
What this trial is testing

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Addex Pharma S.A. 83
Large-scale testing (Phase 3)Study completedNCT03260894
What this trial is testing

Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

Who this might be right for
Renal Cell Carcinoma (RCC)
Incyte Corporation 129
Large-scale testing (Phase 3)Active Not RecruitingNCT05899049
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 251
Early research (Phase 1)Study completedNCT04153565
What this trial is testing

Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)

Who this might be right for
Mesothelioma
Merck Sharp & Dohme LLC 19
Early research (Phase 1)Study completedNCT00252850
What this trial is testing

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
Sangamo Therapeutics 12
Not applicableStudy completedNCT03193489
What this trial is testing

Two-year Follow-up to High-intensity Multi-component Agility Intervention That Improves Clinical and Motor Symptoms of Parkinson's Disease

Who this might be right for
Follow upParkinson DiseaseRehabilitation
Somogy Megyei Kaposi Mór Teaching Hospital 3
Large-scale testing (Phase 3)Looking for participantsNCT06623422
What this trial is testing

Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 680
Next Page